REPORT HIGHLIGHT
The parenteral nutrition market is estimated to represent a global market of USD 5.69 billion by 2019 with growth rate of 11.6%.
Market Dynamics
Parenteral nutrition (also termed as Total Parenteral Nutrition) is a sterile solution that contains macronutrient (i.e. lipid, carbohydrate etc.) and micronutrient (minerals, vitamins etc.). The solution is directly infused into the bloodstream through an intravenous infusion pump, bypassing the digestive system. Special types of intravenous catheters such as Broviac, Hickman, and triple or double lumen catheters are used for this purpose. The growth of this industry is majorly attributed to the rising number of malnutrition cases across the globe. According to the Global Alliance for Improved Nutrition, more than two billion people suffer from a different form of malnutrition worldwide. As per the organization, globally, more than 2.6 million children die due to the lack of proper nutrition every year.
Parenteral nutrition enables an individual in achieving proper nutritional intake in a timely manner. Thereby, the demand for nutrient uptake through the parenteral route is increasing with the rising number of people with malnutrition, driving the industry growth. Other factors such as an aging population coupled with rising prevalence of chronic medical conditions spur the growth of this industry over the forecast period. On the contrary, potential complications associated with parenteral nutrition such as Intravenous access-related trauma, Air embolus, and Thrombophlebitis hampers the market growth to some extent.
Nutrient Type Takeaway
In terms of nutrient type, the market is categorized as Parenteral Lipid Emulsion, Carbohydrates, Trace elements, Single Dose Amino Acid Solution, and Vitamins & Minerals. Single dose amino acid solution accounted for the highest share. In 2017, the segment recorded USD 1.5 billion and is projected to dominate the industry over the study period. Developing regions such as the Asia Pacific and Latin America are the target market for single dose amino acid solutions owing to the rising incidences of protein deficiency diseases such as Kwashiorkor and Marasmus. Nirmin (Nirlife Pharma) and Aminosyn (Hospira, Inc.) are some of the commercially available products under this segment. However, parenteral lipid emulsions and carbohydrates are anticipated to grow with a lucrative growth rate over the study period.
Cumulative Impact of COVID-19:
This research amplifies our efforts to ensure the inclusion of ongoing COVID-19 impacts and potential paths forward. The proposed report is delivering insights on COVID-19 considering the changes in consumer demand, re-routing of the supply chain, purchasing patterns, dynamics of current market forces, and the significant interventions of governments. The updated study provides estimations, insights, analysis, and forecast, considering the COVID-19 impact on the industry.
Regional Takeaway
Region wise, North America and Europe accounted for more than 75% revenue share collectively in 2017. Aggressive strategies adopted by leading players to expand their presence in these regions act as a potential driver for industry growth. For instance, in August 2017, Baxter collaborated with the American Society for Parenteral and Enteral Nutrition (ASPEN) which aims to increase awareness regarding the appropriate use of nutritional therapy.
The initiation is named as “SmartPN” that provides healthcare professionals with educational tools on the proper use of PN therapy that helps in reducing malnutrition cases and achieve better health outcomes. Asia Pacific accounted for over 14% revenue share in 2017 and is projected to grow with 6.9% CAGR over the study period. Growing geriatric population, rising demand for home healthcare coupled with increasing prevalence of chronic diseases support the regional growth.
Key Vendor Takeaway
Key players such as Fresenius Kabi AG, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., and Allergan Plc are operating in this market. These key players are actively involved in improving the current portfolio of parenteral nutrition in order to sustain their position in the market. For example, Baxter offers one of the broadest portfolios under parenteral nutrition segment, which includes vitamins and lipids, premix IV solutions, as well as labelling, pharmacy workflow management, and compounding technology. Additionally, the company received marketing authorization for its product NUMETA G13E from the competent authorities in the Denmark and U.K.
The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018
Base Year – 2019
Estimated Year – 2020
Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY NUTRIENT TYPE
Parenteral Lipid Emulsion
Carbohydrates
Trace Elements
Single Dose Amino Acid Solution
Vitamins & Minerals
MARKET, BY REGION
North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
India
China
Rest of APAC
Rest of the World
Middle East and Africa
Latin America